A Novel Encoded Particle Technology that Enables Simultaneous Interrogation of Multiple Cell Types

The authors have developed a cellular analysis platform, based on encoded microcarriers, that enables the multiplexed analysis of a diverse range of cellular assays. At the core of this technology are classes of microcarriers that have unique, identifiable codes that are deciphered using CCD-based imaging and subsequent image analysis. The platform is compatible with a wide variety of cellular imaging-based assays, including calcium flux, reporter gene activation, cytotoxicity, and proliferation. In addition, the platform is compatible with both colorimetric and fluorescent readouts. Notably, this technology has the unique ability to multiplex different cell lines in a single microplate well, enabling scientists to perform assays and data analysis in novel ways.

[1]  M. Natan,et al.  Solution and chip arrays in protein profiling. , 2001, Trends in biotechnology.

[2]  S. Nie,et al.  Luminescent quantum dots for multiplexed biological detection and imaging. , 2002, Current opinion in biotechnology.

[3]  M. Montminy,et al.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB , 1988, Nature.

[4]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[5]  J. Groves,et al.  Membrane array technology for drug discovery. , 2002, Current opinion in drug discovery & development.

[6]  A. Mazumder,et al.  Suspension arrays for high throughput, multiplexed single nucleotide polymorphism genotyping. , 2000, Cytometry.

[7]  T. Martins.  Development of Internal Controls for the Luminex Instrument as Part of a Multiplex Seven-Analyte Viral Respiratory Antibody Profile , 2002, Clinical and Vaccine Immunology.

[8]  J. Weinstein,et al.  Molecular targets in cancer drug discovery: cell-based profiling. , 2000, Current pharmaceutical design.

[9]  R. G. Freeman,et al.  Submicrometer metallic barcodes. , 2001, Science.

[10]  J P Nolan,et al.  Suspension array technology: new tools for gene and protein analysis. , 2001, Cellular and molecular biology.

[11]  H. Lehrach,et al.  Protein Array Technology , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[12]  K. Pearce,et al.  Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. , 2001, Cytometry.

[13]  N. Papadopoulos,et al.  An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. , 1994, Journal of immunological methods.

[14]  K. Parang,et al.  Current targets for anticancer drug discovery. , 2003, Current drug targets.

[15]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[16]  B. Jonsson,et al.  Differential activity of topotecan, irinotecan and SN-38 in fresh human tumour cells but not in cell lines. , 2000, European journal of cancer.

[17]  J. Schanstra,et al.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. , 1998, The Journal of clinical investigation.

[18]  R. Cone,et al.  A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways. , 1995, Analytical biochemistry.

[19]  J. Verweij,et al.  Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. , 2002, Current cancer drug targets.

[20]  Z. Khaing,et al.  Detection of cell proliferation and cell fate in adult CNS using BrdU double-label immunohistochemistry. , 2003, Methods in Molecular Medicine.

[21]  H. Lehrach,et al.  Protein array technology: the tool to bridge genomics and proteomics. , 2002, Advances in biochemical engineering/biotechnology.

[22]  K. Kinzler,et al.  Use of isogenic human cancer cells for high-throughput screening and drug discovery , 2001, Nature Biotechnology.

[23]  R. Anthony,et al.  DNA array technology and diagnostic microbiology , 2001, Expert review of molecular diagnostics.

[24]  Simon Goldbard,et al.  High-throughput cell analysis using multiplexed array technologies. , 2002, Drug discovery today.

[25]  M. Verma,et al.  Proteomics for cancer biomarker discovery. , 2002, Clinical chemistry.

[26]  Jones Sf,et al.  Topoisomerase I inhibitors: topotecan and irinotecan. , 1996, Cancer practice.